MAPT and tauopathy: Since both AD-tau and FTLD-tau share many post-translational modifications, previously available tau antibodies failed to distinguish between these forms of tauopathy confounding the assessment of Braak AD-tau staging in patients with co-existent FTLD-tau [30, 31, 36, 47].